Torrent Pharmaceuticals share news, announcements and annual reports
NSE: TORNTPHARMBSE: 500420Pharmaceuticals & BiotechnologyLarge Cap
Torrent Pharmaceuticals Limited · Face value ₹5 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 1994 on BSE, Nov 2002 on NSE
Last close ₹4,613.40up ₹33.40 (0.73%)BSE ₹4,635.15
Share price at the NSE close on 30 Oct 2026. Previous close ₹4,580.00.
30 Oct: open ₹4,560.00, high ₹4,672.00, low ₹4,532.00
52-week range of traded prices to 30 Oct 2026
₹3,532.60Low, 6 Nov 2025₹5,250.00High, 3 Aug 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,75,479 Cr61st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 82.62
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 9.55
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.82%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 15.8%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 12.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.76
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 4,36,64564.6% delivered
Torrent Pharmaceuticals board and management
48 filed, newest first.
Oct 2026
16 Oct · Management
Aug 2026
1 Aug · Management
Jul 2026
30 Jul · Management
Jan 2026
Jul 2025
28 Jul · Management
28 Jul · Management
Feb 2025
Aug 2024
13 Aug · Management
Jul 2024
23 Jul · Management
May 2024
24 May · Management
24 May · Management
Apr 2024
1 Apr · Management
Feb 2024
29 Feb · Management
Sep 2023
30 Sep · Management
Aug 2023
Jul 2022
May 2022
Jan 2021
Jan 2020
27 Jan · Management
Jul 2019
23 Jul · Management
May 2019
20 May · Management
Apr 2019
1 Apr · Management
Mar 2019
Aug 2018
2 Aug · Management
Jul 2018
26 Jul · Management
Jul 2017
Jul 2015
May 2015
18 May · Management
Smt. Bhavna Doshi, Independent Directors, has resigned from the Board of Directors of the Company with effect from the conclusion of the Board meeting held on May 15, 2015.
Jul 2014
Jul 2013
29 Jul · Management
Following changes in the directorate of the Company as approved by the Shareholders at their Annual General Meeting (AGM) held on July 26, 2013: (1) Dr. Prasanna Chandra has ceased to be a Director of the Company due to his retirement from the Board with effect from the conclusion of AGM above. (2) Shri. Sanjay Lalbhai has ceased to be a Director of the Company due to his retirement from the Board with effect from the conclusion of AGM above. (3) Shri. Pradeep Bhargava (who was earlier appointed as Additional Director by the Board of Directors at its meeting held on October 26, 2012) has been appointed as Director (Independent Non-Executive) of the Company w.e.f. July 26, 2013, liable to retire by rotation.
Oct 2012
26 Oct · Management
Board of Directors at their meeting held on October 26, 2012 has appointed Shri Pradeep Bhargava as Additional Director (Independent and Non-Executive) on the Board of the Company w.e.f. October 26, 2012.
Jul 2012
24 Jul · Management
Changes in the directorate of the Company as approved by the Shareholders at their Annual General Meeting (AGM) held on July 23, 2012: (1) Shri Shashikant Bhojani has ceased to be a Director of the Company due to his retirement from the Board with effect from the conclusion of AGM above. (2) Dr. Leena Srivastava (who was earlier appointed as Additional Director by the Board of Directors at its meeting held on October 18, 2011) has been appointed as Director (Independent Non-Executive) of the Company w.e.f. July 23,2012, liable to retire by rotation; and (3) Mr Haigreve Khaitan (who was earlier appointed as Additional Director by the Board of Directors at its meeting held on January 23, 2012) has been appointed as Director (Independent Non-Executive) of the Company w.e.f. July 23, 2012, liable to retire by rotation.
Jan 2012
24 Jan · Management
Board of Directors at their meeting held on January 23, 2012 has appointed Haigreve khaitan as Additional Director (Independent & Non-Executive) on the Board of the Company w.e.f. January 23, 2012.
Oct 2011
19 Oct · Management
Board of Directors of the Company at its meeting held on October 18, 2011, inter alia, has approved the following changes in the directorate of the Company: (1) Dr. Chaitanya Dutt, has been re-appointed as Director (Research & Development) of the Company w.e.f. January 01, 2012 for a period of 3 years, subject to approval of the shareholders at their next General Meeting.(2) Dr. Leena Srivastava has been appointed as Additional Director of the Company w.e.f. October 18, 2011.(3) Renu Sud Karnad has ceased to be a Director of the Company w.e.f. October 10, 2011 due to her resignation.
Oct 2010
25 Oct · Management
Following changes have take place in the directors of the Company with immediate effect, as taken up by the Board in its meeting held on October 23, 2010:(1) Acceptance of the resignation of Kiran Karnik as Director of the Company.(2) Appointment of Shailesh V. Haribhakti as an additional director on the Board.
Jul 2009
29 Jul · Management
Torrent Pharmaceuticals Ltd. has informed the Exchange regarding the auditor's report with respect to the audited financial results for the quarter ended June 30, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements For more details click here.
May 2009
19 May · Management
Torrent Pharmaceuticals Ltd. has submitted to the Exchange the auditor's report in respect of the Consolidated Financial results for the year ended March 31, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.12 May · Management
Torrent Pharmaceuticals Ltd. has informed the Exchange that: "Mihir Thakore, Non Executive Independent Director has tendered his resignation as Director of the Company wef 6-May-09. He has communicated that due to his professional commitments, he was finding it increasingly difficult to devote the required time to affairs of the Board & Audit Committee".
Jan 2009
30 Jan · Management
Torrent Pharmaceuticals Ltd. has submitted to the Exchange the auditor's report in respect of the audited financial results for the quarter ended December 31, 2008.A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
May 2008
13 May · Management
Torrent Pharmaceuticals Ltd. has informed the Exchange that : "Prof .S. Ramnarayan, Non Executive Independent Director has tendered his resignation as Director of the Company wef 7-May-08".